课题基金 / 基金详情

CRYSTALLOGRAPHIC STUDIES ON HUMAN CYTOCHROME P450 3A4

CRYSTALLOGRAPHIC STUDIES ON HUMAN CYTOCHROME P450 3A4
人细胞色素 P450 3A4 的晶体学研究
批准号:
8170293
负责人:
IRINA F SEVRIOUKOVA
金额:
$0.03万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-05-01 至 2011-02-28

项目摘要

项目成果

IRINA F SEVRIOUKOVA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Cytochrome P450 3A4 (CYP3A4) is the major zenobiotic- and drug-metabolizing human enzyme that is also involved in carcinogen activation. One of the areas significantly affected by the CYP3A4-mediated enzymatic transformations is development of anti-HIV drugs. To date, only a limited number of low-resolution x-ray structures of CYP3A4 complexes with substrates, drugs and inhibitors are available. To better understand the mechanism of CYP3A4 catalysis and inhibition, we obtained crystals of the enzyme bound to various substrates and inhibitors and aim to extend their resolution by collecting synchrotron data.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CRYSTALLOGRAPHIC STUDIES ON HUMAN CYTOCHROME P450 3A4
  • 批准号:
    8362292
  • 项目类别:
  • 资助金额:
    $0.64万
  • 财政年份:
    2011
  • 负责人:
    IRINA F SEVRIOUKOVA
  • 依托单位:
STRUCTURE OF NATURALLY FOLDED APOPTOSIS INDUCING FACTOR
  • 批准号:
    8170095
  • 项目类别:
  • 资助金额:
    $0.03万
  • 财政年份:
    2010
  • 负责人:
    IRINA F SEVRIOUKOVA
  • 依托单位:
STRUCTURE OF NATURALLY FOLDED APOPTOSIS INDUCING FACTOR
  • 批准号:
    7954422
  • 项目类别:
  • 资助金额:
    $0.39万
  • 财政年份:
    2009
  • 负责人:
    IRINA F SEVRIOUKOVA
  • 依托单位:
STRUCTURE OF NATURALLY FOLDED APOPTOSIS INDUCING FACTOR
  • 批准号:
    7722113
  • 项目类别:
  • 资助金额:
    $0.11万
  • 财政年份:
    2008
  • 负责人:
    IRINA F SEVRIOUKOVA
  • 依托单位:
海外基金